MedTrace Logo

New Prognostic Kidney Function Markers in Emergency Patients New Markers of Kidney Function in ED Patients

NCT02261909 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-08-22

No results posted yet for this study

Summary

NephroCheck is measuring the concentration of a certain protein combination in the urine of patients. In elevated values there is a probability of renal failure (already proven in intensive care patients). The investigators would like to investigate whether the investigators can predict renal failure in patients receiving contrast enhanced CT's in the emergency department. That would lead to an earlier nephrologist consult in those patients.

Conditions

Sponsors & Collaborators

  • Astute Medical, Inc.

    collaborator INDUSTRY

  • Krankenhaus Barmherzige Brüder, Regensburg

    lead OTHER

Principal Investigators

  • Jan Braess, Prof · Krankenhaus Barmherzige Brüder

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261909 on ClinicalTrials.gov